Speciality: Endocrinology
Description:
A warm welcome to all the medical professionals in this interesting session on Understanding Type 2 Diabetes - Latest Guidelines.
The latest guidelines for understanding and managing Type 2 diabetes emphasize early diagnosis and regular screening, especially for high-risk populations. The American Diabetes Association (ADA) recommends using HbA1c, fasting plasma glucose (FPG), or an oral glucose tolerance test (OGTT) for diagnosing diabetes. Individuals with a body mass index (BMI) of 25 or higher (23 or higher in Asian Americans) and additional risk factors such as hypertension, dyslipidemia, or a family history of diabetes should be screened regularly. Early detection is crucial for initiating timely interventions to prevent complications
Current guidelines advocate for a personalized approach to managing Type 2 diabetes, focusing on lifestyle modifications as the first line of treatment. This includes dietary changes, increased physical activity, and weight loss. Pharmacologic interventions are tailored based on individual patient profiles, with metformin remaining the preferred initial medication. The addition of other agents, such as SGLT2 inhibitors or GLP-1 receptor agonists, may be considered based on the patient's cardiovascular health, risk of hypoglycemia, and other comorbidities. The goal is to achieve and maintain target blood glucose levels, minimizing the risk of both acute and chronic complications
Therefore, get an overall knowledge of understanding type 2 diabetes - latest guidelines.
See More Webinars @ Hidoc Webinars
1.
Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.
2.
Relationship-building key to addressing oncologist shortages in rural care
3.
A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.
4.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
5.
Prostate cancer therapies: AI-based image analysis detects early organ damage
1.
Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice
2.
Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon
3.
Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment
4.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
5.
Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation